Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

GLG Webcast: FDA Drug Reviews - Policies and Procedures - November 6, 2008 at 2:00 PM EDT

Time & Location

Originally Presented: November 6, 2008 2:00 PM

Presenter(s):

GLG Expert Contributor

Agenda:

    IMPORTANT Please click the above link in the location field to access the Webcast. To participate, attendees must have pre-registered on the GLG Research Management Platform (RMP) prior to 5:00 PM EST on Tuesday, November 4, 2008. TOPICS
  • Will every drug need a REMS and what does that mean for drug reviews?
  • How high will the FDA set the bar for safety in the wake of Vioxx?
  • What efficacy issues, ranging from comparative effectiveness to patient reported outcomes (PRO), still remain unclear? ABOUT GLG WEBCASTS Webcasts educate business and investment professionals through online presentations on current trends and core concepts in various industries. GLG Webcasts typically consist of a 30-minute presentation, followed by a Q&A session. Presentation audio is delivered via attendees' computers.

View Webcasts & Teleconferences in Legal, Economic & Regulatory Affairs

View All Webcasts & Teleconferences in Legal, Economic & Regulatory Affairs

Learn More About GLG Live Meetings

About GLG Live Meetings

A program focused on educating business and investment professionals through seminars on current trends and core concepts in various industries. Detailed workbooks distributed at the Seminars provide educational reference materials for later review. GLG Live Meetings enable clients to increase thier own industry education by proposing new seminar topics or adding agenda terms to currently scheduled seminars.